ICU MED INC's ticker is ICUI and the CUSIP is 44930G107. A total of 248 filers reported holding ICU MED INC in Q4 2016. The put-call ratio across all filers is 0.97 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $167,766,000 | +31.9% | 1,138,554 | +13.2% | 0.03% | +19.2% |
| Q3 2016 | $127,156,000 | +21.1% | 1,006,142 | +8.0% | 0.03% | +13.0% |
| Q2 2016 | $105,020,000 | +12.9% | 931,445 | +4.3% | 0.02% | +4.5% |
| Q1 2016 | $92,991,000 | -8.0% | 893,284 | -0.3% | 0.02% | -4.3% |
| Q4 2015 | $101,036,000 | +9.1% | 895,866 | +5.9% | 0.02% | -4.2% |
| Q3 2015 | $92,637,000 | +19.5% | 845,997 | +4.4% | 0.02% | +26.3% |
| Q2 2015 | $77,494,000 | +5.7% | 810,102 | +2.9% | 0.02% | +5.6% |
| Q1 2015 | $73,346,000 | +21.1% | 787,478 | +6.5% | 0.02% | +20.0% |
| Q4 2014 | $60,547,000 | +41.5% | 739,274 | +10.9% | 0.02% | +25.0% |
| Q3 2014 | $42,798,000 | +2.2% | 666,848 | -3.2% | 0.01% | 0.0% |
| Q2 2014 | $41,896,000 | -3.4% | 688,965 | -4.9% | 0.01% | -7.7% |
| Q1 2014 | $43,362,000 | -4.0% | 724,153 | +2.2% | 0.01% | -7.1% |
| Q4 2013 | $45,151,000 | -3.3% | 708,698 | +3.1% | 0.01% | -12.5% |
| Q3 2013 | $46,675,000 | +6.5% | 687,111 | +13.0% | 0.02% | 0.0% |
| Q2 2013 | $43,817,000 | – | 608,063 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| EVR Research LP | 22,000 | $4,719,000 | 3.86% |
| NUANCE INVESTMENTS, LLC | 901,483 | $193,359,000 | 3.73% |
| Nitorum Capital, L.P. | 417,241 | $89,494,000 | 3.46% |
| Tamarack Advisers, LP | 73,000 | $15,452,000 | 3.22% |
| PFM Health Sciences, LP | 267,817 | $57,444,000 | 2.02% |
| KIRR MARBACH & CO LLC /IN/ | 22,222 | $4,766,000 | 1.49% |
| PURA VIDA INVESTMENTS, LLC | 174,399 | $37,407,000 | 1.36% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 2,584 | $554,000 | 0.88% |
| Findlay Park Partners LLP | 528,825 | $113,428,000 | 0.79% |
| Altium Capital Management LP | 9,321 | $1,999,000 | 0.75% |